What's breaking now, across thousands of outlets.
The FDA previously hadn’t ever accepted an application of a drug like fenebrutinib in two major forms of MS. But safety questions still hang over Roche’s program.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing government health coverage starting Oct. 1.
This October, Waze will help drivers find screening clinics, assess their health risks, and schedule routine checkups.
Rep. Gregory F. Murphy proposed that Medicare Advantage plans should be allowed to provide nutritious food as a targeted clinical intervention to help seniors manage chronic diseases and prevent…
For children participating in a six-minute walk test at the University of Kentucky, a trip down the clinic hallway can now become something more: a game.
